WO2007067611A3 - Methods of treating cardiac reperfusion disease - Google Patents

Methods of treating cardiac reperfusion disease Download PDF

Info

Publication number
WO2007067611A3
WO2007067611A3 PCT/US2006/046538 US2006046538W WO2007067611A3 WO 2007067611 A3 WO2007067611 A3 WO 2007067611A3 US 2006046538 W US2006046538 W US 2006046538W WO 2007067611 A3 WO2007067611 A3 WO 2007067611A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
treating cardiac
cardiac reperfusion
reperfusion disease
compositions
Prior art date
Application number
PCT/US2006/046538
Other languages
French (fr)
Other versions
WO2007067611A2 (en
Inventor
Howard Weiner
Daniel Frenkel
Victor J Dzau
Alok S Pachori
Original Assignee
Brigham & Womens Hospital
Howard Weiner
Daniel Frenkel
Victor J Dzau
Alok S Pachori
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham & Womens Hospital, Howard Weiner, Daniel Frenkel, Victor J Dzau, Alok S Pachori filed Critical Brigham & Womens Hospital
Publication of WO2007067611A2 publication Critical patent/WO2007067611A2/en
Publication of WO2007067611A3 publication Critical patent/WO2007067611A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Described herein are methods and compositions for treating or preventing cardiac reperfusion diseases. The methods include administering, e.g., mucosally, e.g., nasally, a therapeutically effective amount of a composition comprising a cardiac autoantigen, e.g., a troponin polypeptide. Also described are compositions and kits including troponin, e.g., for use in the methods described herein.
PCT/US2006/046538 2005-12-07 2006-12-06 Methods of treating cardiac reperfusion disease WO2007067611A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74824705P 2005-12-07 2005-12-07
US60/748,247 2005-12-07

Publications (2)

Publication Number Publication Date
WO2007067611A2 WO2007067611A2 (en) 2007-06-14
WO2007067611A3 true WO2007067611A3 (en) 2008-03-06

Family

ID=38123450

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/046538 WO2007067611A2 (en) 2005-12-07 2006-12-06 Methods of treating cardiac reperfusion disease

Country Status (1)

Country Link
WO (1) WO2007067611A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210038687A1 (en) * 2019-08-07 2021-02-11 Wayne State University Compositions and methods relating to a c-terminal peptide of troponin i with activity as a myofilament ca2+ desensitizer

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0753312A1 (en) * 1993-09-29 1997-01-15 Kirin Beer Kabushiki Kaisha Arteriosclerosis remedy
WO1997030085A1 (en) * 1996-02-16 1997-08-21 Children's Medical Center Corporation Troponin subunits and fragments useful as angiogenesis inhibitors

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0753312A1 (en) * 1993-09-29 1997-01-15 Kirin Beer Kabushiki Kaisha Arteriosclerosis remedy
WO1997030085A1 (en) * 1996-02-16 1997-08-21 Children's Medical Center Corporation Troponin subunits and fragments useful as angiogenesis inhibitors

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
FRENKEL D ET AL: "Neuroprotection by IL-10-producing MOG CD4+ T cells following ischemic stroke Preserve the Neuron. Brain Atrophy, Axonal Loss, Remyelination and Stem Cells in MS. European Charcot Foundation Symposium", JOURNAL OF THE NEUROLOGICAL SCIENCES 15 JUN 2005 NETHERLANDS, vol. 233, no. 1-2, 15 June 2005 (2005-06-15), pages 125 - 132, XP004932292, ISSN: 0022-510X *
SCIRICA BENJAMIN M ET AL: "Troponins in acute coronary syndromes.", SEMINARS IN VASCULAR MEDICINE NOV 2003, vol. 3, no. 4, November 2003 (2003-11-01), pages 363 - 374, XP009047291, ISSN: 1528-9648 *

Also Published As

Publication number Publication date
WO2007067611A2 (en) 2007-06-14

Similar Documents

Publication Publication Date Title
IL291162A (en) Isolated human rpe cells and use thereof for the treatment of degenerative diseases of the retina
EP2175834B8 (en) Glp-1-fc fusion protein formulation
WO2006035237A3 (en) Methods and compositions relating to alzheimer's disease
WO2006034373A3 (en) Variants and chemically-modified variants of phenylalanine ammonia-lyase
WO2006124012A3 (en) Compounds for treating alzheimer's disease and for inhibiting beta-amyloid peptide production
WO2005116088A3 (en) Methods and compositions for treating diseases and disorders associated with siglec-8 expressing cells
WO2007067519A3 (en) The use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditions
WO2005067546A3 (en) Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases
WO2007009894A3 (en) Peptides for use in the treatment of obesity
WO2006113978A3 (en) Insulins combinations
WO2006048450A3 (en) Peptides for use in the treating obesity
WO2005094554A3 (en) Therapeutic agents, methods, and treatments
WO2006048452A3 (en) Peptides for use in treating of obesity
WO2007056301A3 (en) Antibody therapy for treatment of diseases associated with gluten intolerance
WO2007061924A3 (en) Methods of treating cartilage defects
AU2003229284A1 (en) Active substances for the treatment, diagnosis and prophylaxis of diseases in which abnormal protein structures occur
WO2007025229A3 (en) Compositions and their uses directed to hsp27
WO2007109648A8 (en) Compositions and methods for modulating store-operated calcium entry
WO2007134118A3 (en) Protein based composition and methods of using same
WO2005123113A3 (en) Interferon compositions and methods of use thereof
TWI347845B (en) Pharmaceutical compositions,combinations,and kits for the treatment of respiratory diseases and use of the same
WO2007067611A3 (en) Methods of treating cardiac reperfusion disease
WO2006134101A3 (en) Use of pde1c and inhibitors thereof
WO2006004774A3 (en) Laulimalide analogues as therapeutic agents
WO2006055404A3 (en) Compounds for targeting mechanisms implicated in the progression of stroke

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 06844887

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 06844887

Country of ref document: EP

Kind code of ref document: A2